MLTX icon

MoonLake Immunotherapeutics
MLTX

Overview Fund Trends Analyst Outlook Journalist POV

46 hedge funds and large institutions have $122M invested in MoonLake Immunotherapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11.5M
2
+$8.53M
3
+$8.53M
4
RI
RTW Investments
New York
+$8.53M
5
RCM
RA Capital Management
Massachusetts
+$7.96M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.66M
27
$796K
28
$693K
29
$571K
30
$565K
31
$524K
32
$485K
33
$393K
34
$257K
35
$227K
36
$227K
37
$182K
38
$164K
39
$154K
40
$108K
41
$108K
42
$103K
43
$57K
44
$2K
1
2